Literature DB >> 31957027

The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.

Victoria R Votaw1, Matthew R Pearson2, Elena Stein1, Katie Witkiewitz1.   

Abstract

BACKGROUND: The Addictions Neuroclinical Assessment (ANA), a framework for measuring heterogeneity in alcohol use disorder (AUD), focuses on 3 domains that reflect neurobiological dysfunction in addiction and correspond to the cycles of addiction: executive function, incentive salience, and negative emotionality. Kwako and colleagues (Am J Psychiatry 176:744, 2019) validated a 3-factor model of the ANA with neuropsychological and self-report indicators among treatment-seekers and non-treatment-seekers with and without AUD. The present analysis replicated and extended these findings in a treatment-seeking sample, focusing on the negative emotionality domain.
METHODS: Participants (n = 563; 58.8% male; mean age = 34.3) were part of a multisite prospective study of individuals entering AUD treatment. We examined the factor structure of the negative emotionality domain at the baseline, 6-month follow-up, and 12-month follow-up assessments. The Beck Depression Inventory, Beck Anxiety Inventory, State-Trait Anger Expression Inventory-Trait Anger Subscale, and 3 Drinker Inventory of Consequences items assessing negative affective consequences were indicators in the model.
RESULTS: Results indicated that a 1-factor model was an excellent fit at all assessments and that the negative emotionality domain was time and gender invariant. Furthermore, negative emotionality was associated with drinking patterns and reasons for alcohol use (i.e., drinking because of negative emotions and urges/withdrawal) at all assessments.
CONCLUSIONS: This analysis provides evidence for the construct validity and measurement invariance of the ANA negative emotionality domain among AUD treatment-seekers. Future studies are needed to evaluate prospective associations between negative emotionality and specific treatment modalities, and whether individuals with greater negative emotionality are more likely to respond to treatment that targets drinking to relieve negative affective states.
© 2020 by the Research Society on Alcoholism.

Entities:  

Keywords:  Addiction Cycle; Addictions Neuroclinical Assessment; Alcohol Relapse; Alcohol Use Disorder Treatment; Negative Emotions

Year:  2020        PMID: 31957027      PMCID: PMC7069798          DOI: 10.1111/acer.14283

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  34 in total

1.  Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.

Authors:  Corey R Roos; Sarah Bowen; Katie Witkiewitz
Journal:  J Consult Clin Psychol       Date:  2017-11

2.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

3.  Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.

Authors:  Karl Mann; Corey R Roos; Sabine Hoffmann; Helmut Nakovics; Tagrid Leménager; Andreas Heinz; Katie Witkiewitz
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853

4.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

5.  The impact of comorbid anxiety and depression on alcohol treatment outcomes.

Authors:  Lucy Burns; Maree Teesson; Katy O'Neill
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

Review 6.  Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again.

Authors:  Kathleen M Carroll; Brian D Kiluk
Journal:  Psychol Addict Behav       Date:  2017-08-31

Review 7.  Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).

Authors:  Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

8.  Commentary: Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.

Authors:  Udi E Ghitza
Journal:  Front Psychiatry       Date:  2017-01-13       Impact factor: 4.157

Review 9.  Advances in the science and treatment of alcohol use disorder.

Authors:  K Witkiewitz; R Z Litten; L Leggio
Journal:  Sci Adv       Date:  2019-09-25       Impact factor: 14.136

10.  Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.

Authors:  Katie Witkiewitz; Corey R Roos; Karl Mann; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2019-09-11       Impact factor: 3.455

View more
  7 in total

1.  The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews.

Authors:  Cassandra L Boness; Ashley L Watts; Kimberly N Moeller; Kenneth J Sher
Journal:  Psychol Bull       Date:  2021-10       Impact factor: 17.737

2.  The profound heterogeneity of substance use disorders: Implications for treatment development.

Authors:  Kathleen M Carroll
Journal:  Curr Dir Psychol Sci       Date:  2021-07-16

3.  Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine.

Authors:  Steven J Nieto; Lara A Ray
Journal:  Behav Brain Res       Date:  2022-04-01       Impact factor: 3.352

4.  Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers.

Authors:  Steven J Nieto; Erica N Grodin; ReJoyce Green; Lara A Ray
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

5.  Heterogeneity in DSM-5 Symptom Criteria: Phenotypes of Alcohol Use Disorder in a Sample Seeking Alcohol Treatment.

Authors:  Junru Zhao; Braden Linn; Clara Bradizza; Joseph Lucke; Melanie Ruszczyk; Paul Stasiewicz
Journal:  Alcohol Alcohol       Date:  2021-10-29       Impact factor: 2.826

6.  Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder.

Authors:  Elena R Stein; Victoria R Votaw; Julia E Swan; Katie Witkiewitz
Journal:  J Subst Abuse Treat       Date:  2020-12-03

7.  Anger and substance abuse: a systematic review and meta-analysis.

Authors:  Helen V Laitano; Amanda Ely; Anne O Sordi; Felipe B Schuch; Flavio Pechansky; Thiago Hartmann; Juliana B Hilgert; Eliana M Wendland; Lisia Von Dimen; Juliana N Scherer; Alessandra Mendes Calixto; Joana C M Narvaez; Felipe Ornell; Félix H P Kessler
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.